Shenzhen TargetRx
PrivateLast Round
Series C
Jan 23, 2025
Total Funding Raised
$106M
Company Overview
Shenzhen TargetRx is a clinical-stage pharmaceutical company that specializes in the research and development of targeted small molecule anti-cancer therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shenzhen TargetRx Comparables
Compare Shenzhen TargetRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nuvalent, Inc. | 78% | |
| Theseus Pharmaceuticals | 78% | |
| Ascentage Pharma Group International | 76% |
Shenzhen TargetRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 23, 2025 | ||||
| Strategic | Sep 7, 2024 | ||||
| Series B | Jul 5, 2022 | ||||
| Strategic | Sep 17, 2020 | ||||
| Series A | Apr 30, 2020 | ||||
Pre Seed | Jul 25, 2018 |
Shenzhen TargetRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriental Fortune Capital | Series B, Series A |
| CDH Baifu | Series B |
| CCB International | Series B |
| Shenzhen Capital Group | Series B, Pre Seed, Series A |
| Hongtai Fund | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors grew 283% MoM, from 313 to 1.2K.
- Jan 23, 2025
$50M round completed.
Shenzhen TargetRx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shenzhen TargetRx's valuation, stock price, and market status.
Is Shenzhen TargetRx a public or private company?
Shenzhen TargetRx is a private company.
What is the current stock price of Shenzhen TargetRx?
Shenzhen TargetRx is a private company with no public stock price. No recent secondary market data is available.
How much is Shenzhen TargetRx worth (valuation)?
Valuation information for Shenzhen TargetRx is not publicly available.
Can I buy Shenzhen TargetRx stock?
Shenzhen TargetRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shenzhen TargetRx's last funding round?
Shenzhen TargetRx's most recent funding round was Series C on January 23, 2025.
Who are the main investors in Shenzhen TargetRx?
Key investors in Shenzhen TargetRx include CDH Baifu.
Will Shenzhen TargetRx IPO soon?
No public IPO plans have been announced for Shenzhen TargetRx.
How can I track Shenzhen TargetRx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shenzhen TargetRx's secondary market activity and sign up for updates.